MedTrace Logo

OLIF25™ /OLIF51™ Study

NCT02657421 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2018-06-04

No results posted yet for this study

Summary

The purpose of this single-arm observational study is to observe and document clinical outcomes of the OLIF25™ and OLIF51™ procedures in patients diagnosed with degenerative disc disease or degenerative scoliosis, and report the rate of adverse events of interest through the 24 months follow-up visit.

Conditions

  • Degenerative Disc Disease
  • Scoliosis

Interventions

PROCEDURE

Oblique Lateral Interbody Fusion

The oblique lateral interbody fusion (OLIF) procedures at L2-L5 (OLIF25™) and L5-S1 (OLIF51™) is a minimally invasive surgical option for degenerative lumbar disease. This approach allows for psoas-preserving access to the lumbar spine and minimizes the need to reposition the patient during surgery for accessing additional spinal levels for the interbody fusion portion of the procedure

Sponsors & Collaborators

  • Medtronic Spinal and Biologics

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-05-03
Completion
2018-05-03

Countries

  • United States
  • Belgium
  • Czechia
  • France
  • Italy
  • Portugal
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02657421 on ClinicalTrials.gov